1. Home
  2. NPFD vs PRME Comparison

NPFD vs PRME Comparison

Compare NPFD & PRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NPFD
  • PRME
  • Stock Information
  • Founded
  • NPFD 2021
  • PRME 2019
  • Country
  • NPFD United States
  • PRME United States
  • Employees
  • NPFD N/A
  • PRME N/A
  • Industry
  • NPFD Trusts Except Educational Religious and Charitable
  • PRME Medicinal Chemicals and Botanical Products
  • Sector
  • NPFD Finance
  • PRME Health Care
  • Exchange
  • NPFD Nasdaq
  • PRME Nasdaq
  • Market Cap
  • NPFD 456.7M
  • PRME 424.9M
  • IPO Year
  • NPFD N/A
  • PRME 2022
  • Fundamental
  • Price
  • NPFD $18.86
  • PRME $2.97
  • Analyst Decision
  • NPFD
  • PRME Strong Buy
  • Analyst Count
  • NPFD 0
  • PRME 8
  • Target Price
  • NPFD N/A
  • PRME $13.86
  • AVG Volume (30 Days)
  • NPFD 64.7K
  • PRME 1.0M
  • Earning Date
  • NPFD 01-01-0001
  • PRME 11-12-2024
  • Dividend Yield
  • NPFD 6.28%
  • PRME N/A
  • EPS Growth
  • NPFD N/A
  • PRME N/A
  • EPS
  • NPFD N/A
  • PRME N/A
  • Revenue
  • NPFD N/A
  • PRME $800,000.00
  • Revenue This Year
  • NPFD N/A
  • PRME N/A
  • Revenue Next Year
  • NPFD N/A
  • PRME $21.23
  • P/E Ratio
  • NPFD N/A
  • PRME N/A
  • Revenue Growth
  • NPFD N/A
  • PRME N/A
  • 52 Week Low
  • NPFD $14.50
  • PRME $2.85
  • 52 Week High
  • NPFD $18.07
  • PRME $9.86
  • Technical
  • Relative Strength Index (RSI)
  • NPFD 48.56
  • PRME 30.86
  • Support Level
  • NPFD $18.35
  • PRME $4.03
  • Resistance Level
  • NPFD $19.30
  • PRME $4.49
  • Average True Range (ATR)
  • NPFD 0.26
  • PRME 0.32
  • MACD
  • NPFD -0.01
  • PRME -0.14
  • Stochastic Oscillator
  • NPFD 50.69
  • PRME 6.45

About NPFD Nuveen Variable Rate Preferred & Income Fund

Nuveen Variable Rate Preferred&Income is a newly organized, diversified, closed-end management investment company. The Fund's investment objective is to seek to provide a high level of current income and total return.

About PRME Prime Medicine Inc.

Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.

Share on Social Networks: